ISDS Case Map
India
Stating that incentives should be given for setting up manufacturing bases in the country, SIAM today said it opposes any lowering of customs duty on fully imported cars in the proposed India-EU free trade agreement.
Canadian Industry Minister Tony Clement has reiterated his country's commitment to signing a free trade agreement with India by 2013.
As free trade agreement talks between Europe and India resume in Brussels today, the international medical humanitarian organisation Médecins Sans Frontières (MSF) is deeply concerned about new measures Europe is pushing to restrict the production of affordable generic medicines that MSF and others rely on to treat patients across the developing world.
The outcome of this week's meetings will reveal whether India and the EU can clinch a historic free trade agreement by the summer, Europolitics understands.
This factsheet exposes the inherent dangers of the ‘free trade’ agenda pushed by corporate agribusiness under the aegis of India-EU FTA.
The panel would also clear negotiations for India-Australia FTA and examine setting up a joint study group for a possible free trade pact between India and the Common Market For Eastern and Southern Africa (COMESA).
Six years after India and Thailand executed a limited free-trade agreement involving just 82 products, the two countries are now ready to work on a full-fledged pact in goods, services and investments.
A council headed by Prime Minister Manmohan Singh would deliberate on the feasibility of starting a dialogue on a Free Trade Agreement (FTA) between India and Australia, besides a more comprehensive agreement with Indonesia.
Korean companies should be prepared for fierce competition with Japanese rivals in India following New Delhi’s signing of a free trade agreement with Tokyo, a local trade body said yesterday.
The government on Tuesday took a firm stand on protection of intellectual property rights and the aspect of data exclusivity for drug manufacturers saying that the country would not extend data exclusivity that would hamper the domestic pharma industry.
